PortfoliosStock ScreensStocksStockXcel

LYRA THERAPEUTICS INC

LYRA | US

0.67

USD

0.01

1.52%

LYRA | US

About LYRA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Earnings date

30/06/2024

As of date

15/04/2026

Close

0.67

Open

0.66

High

0.67

Low

0.66

Lyra Therapeutics Inc. a clinical-stage biotechnology company focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear nose and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210 an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS) which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical Inc. and changed its name to Lyra Therapeutics Inc. in July 2018. Lyra Therapeutics Inc. was incorporated in 2005 and is headquartered in Watertown Massachusetts.

View Less

LYRA | US

Risk
258.2
Sharpe
-0.27
Luna's Score
48/100
Recommendation
Hold

Luna says (LYRA | US)

What's Working

Low Market Beta (-0.4 to 0.8)

Value Stock (Price to Book < 3)

Strong Revenue Growth (> 10%)

What's not Working

High 6-Month Volatility (>65%)

Microcap (<300M USD)

High Debt to Equity (> 0.75)

Weak Operating Margin (< 10%)

Weak Sharpe Ratio (< 0.3)

Volatility Signals

Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.

Risk Meter

10 days

121.9%

1 month

258.2%

3 months

184.3%

6 months

156.6%

Returns

Fundamental Ratios

PE

-

Fwd. PE

-

Price to book

0.49

Debt to equity

1.19

Debt to assets

0.39

Ent. to EBITDA

0.66

Ent. to rev.

153.77

PEG

-

Other Fundamentals

EBITDA

-74.33M

MarketCap

43.86M

MarketCap(USD)

43.86M

Div. yield

-

Op. margin

-2.98K

Erngs. growth

-

Rev. growth

30.60

Ret. on equity

-156.52

Short ratio

4.28

Short perc.

5.44

Market Sentiment (SMA and Price signals)

Short-term: Bullish (SMA10D > SMA1M)

Intermediate-term: Bearish (SMA1M < SMA3M)

Long-term: Bearish (SMA6M < SMA12M)

SMAs: Stock Price Trends

Range10D

0.31

Range1M

1.02

Range3M

2.27

Volumes: Market Activity

Rel. volume

0.02

Price X volume

1.07K

Peers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Tenax Therapeutics IncTENXBiotechnology14.0147.76M-5.21%n/a3.14%
IMNNIMNNBiotechnology3.1545.36M1.61%n/a37.13%
Cognition Therapeutics Inc. Common StockCGTXBiotechnology1.0943.74M11.75%n/a2.71%
Cue Biopharma IncCUEBiotechnology0.724343.61M65.37%n/a52.09%
Minerva Neurosciences IncNERVBiotechnology6.1843.22M5.28%n/a-194.60%
Entera Bio LtdENTXBiotechnology1.1842.86M4.42%n/a3.91%
BioXcel Therapeutics IncBTAIBiotechnology1.0542.78M-0.94%n/a-139.46%
Audentes Therapeutics IncBOLDBiotechnology1.6342.70M4.49%n/a0.47%
CIBUS GLOBAL LTD.CBUSBiotechnology1.4442.47M1.41%n/a81.33%
Werewolf Therapeutics Inc. Common StockHOWLBiotechnology0.919640.19M0.23%n/a35.26%
  • 1

Diversifiers

Name
Ticker
Industry
Close
Marketcap
Day Return
PE Ratio
Debt to Equity
 
 
 
 
 
 
 
 
Beasley Broadcast Group IncBBGIBroadcasting - Radio13.7220.90M-6.98%n/a204.46%
REE Automotive Ltd. Class A Ordinary SharesREERecreational Vehicles0.629912.17M1.11%n/a58.43%
Antelope Enterprise Holdings LimitedAEHLBuilding Products & Equipment0.694710.15M-23.66%0.0316.03%
EZGO Technologies Ltd. Ordinary SharesEZGORecreational Vehicles1.36313.48M3.27%n/a17.32%
Twin Vee PowerCats Co. Common StockVEEERecreational Vehicles0.2312.20M7.49%n/a19.98%
Vision Marine Technologies IncVMARRecreational Vehicles1.74958.74K-6.95%n/a0.00%
Micromobility.com Inc.MCOMRecreational Vehicles0.005461.07K0.00%n/a-37.05%
  • 1

Industry Comparison

ParameterCompanyIndustryIndicator
Enterprise to EBITDA0.66-Expensive
Ent. to Revenue153.77-Cheaper
PE Ratio-41.03-
Price to Book0.4915.55Cheaper
Dividend Yield---
Std. Deviation (3M)184.28-Riskier
Debt to Equity1.19-1.23Expensive
Debt to Assets0.390.25Expensive
Market Cap43.86M-Emerging
  • 1

Unlock Your Investing Potential

Register with Xstocks

Join over 2,000+ Investors

Register now and embark on your journey to informed and successful investing.

Explore Industry Correlations

Explore Industry Correlations

Uncover Trading and Hedging Opportunities

Gain valuable insights into potential trading opportunities and discover strategic hedging possibilities

Discover Top-Performing Industries

Discover Top performing Industries

Explore Stocks for Short and Long-Term Gains

Uncover opportunities at both short-term and long-term horizons, allowing you to make informed investment decisions.

Follow us @XStocks007